Packages (Simulation)
Reagent Preparation
Image (I)
Image (II)
Certificate
Multiplex Assay Kit for Cyclin Dependent Kinase Inhibitor 2A (CDKN2A) ,etc. by CBA (Cytometric Bead Array)
P16; ARF; CDK4I; CMM2; INK4; INK4a; MLM; MTS1; TP16; P14; P14ARF; P16INK4a; P19; Melanoma P16; Cyclin-dependent kinase 4 inhibitor A; Multiple tumor suppressor 1
- Product No.CMA794Mu
- Organism SpeciesMus musculus (Mouse) Same name, Different species.
- Sample TypeTissue homogenates, cell lysates and other biological fluids
- Test MethodDouble-antibody Sandwich
- Assay Length4h
- Detection Range0.0195-20ng/mL
- SensitivityThe minimum detectable dose of this kit is typically less than 0.0065ng/mL.
- DownloadInstruction Manual
- UOM 48T96T
- FOB
US$ 545
US$ 778
For more details, please contact local distributors!
Specificity
This assay has high sensitivity and excellent specificity for detection of Cyclin Dependent Kinase Inhibitor 2A (CDKN2A) ,etc. by CBA (Cytometric Bead Array).
No significant cross-reactivity or interference between Cyclin Dependent Kinase Inhibitor 2A (CDKN2A) ,etc. by CBA (Cytometric Bead Array) and analogues was observed.
Recovery
Matrices listed below were spiked with certain level of recombinant Cyclin Dependent Kinase Inhibitor 2A (CDKN2A) ,etc. by CBA (Cytometric Bead Array) and the recovery rates were calculated by comparing the measured value to the expected amount of Cyclin Dependent Kinase Inhibitor 2A (CDKN2A) ,etc. by CBA (Cytometric Bead Array) in samples.
| Matrix | Recovery range (%) | Average(%) |
| serum(n=5) | 80-103 | 90 |
| EDTA plasma(n=5) | 78-103 | 87 |
| heparin plasma(n=5) | 82-94 | 90 |
Precision
Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Cyclin Dependent Kinase Inhibitor 2A (CDKN2A) ,etc. by CBA (Cytometric Bead Array) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Cyclin Dependent Kinase Inhibitor 2A (CDKN2A) ,etc. by CBA (Cytometric Bead Array) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%
Linearity
The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Cyclin Dependent Kinase Inhibitor 2A (CDKN2A) ,etc. by CBA (Cytometric Bead Array) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.
| Sample | 1:2 | 1:4 | 1:8 | 1:16 |
| serum(n=5) | 86-104% | 78-92% | 93-101% | 78-97% |
| EDTA plasma(n=5) | 95-103% | 95-103% | 80-104% | 90-101% |
| heparin plasma(n=5) | 78-103% | 86-96% | 88-97% | 95-102% |
Stability
The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.
Reagents and materials provided
| Reagents | Quantity | Reagents | Quantity |
Assay procedure summary
1. Add 200μL analysis buffer solution to each well of the plate for pre-wetting;
2. Preparation of standards, reagents and samples before the experiment;
3. Add 100μL standard or sample to each well, add 10μL magnetic beads, and incubate 120 minutes protect from light at 25°C on shaker;
4. Remove liquid on magnetic frame, add 100μL prepared Detection Reagent A. Incubate 60 minutes protect from light at 25°C on shaker;
5. Remove liquid on magnetic frame, add 100μL prepared Detection Reagent B, and incubate 30 minutes protect from light at 25°C on shaker;
6. Wash plate once on magnetic frame;
7. Add 100μL sheath fluid, swirl for 10 minutes, read on the machine.
GIVEAWAYS
INCREMENT SERVICES
| Magazine | Citations |
| Biochemical genetics | Comparison of Selected Protein Levels in Tumour and Surgical Margin in a Group of Patients with Oral Cavity Cancer pubmed:28421310 |
| European Journal of Pharmaceutical Sciences | Development of core-shell nanocarrier system for augmenting piperine cytotoxic activity against human brain cancer cell line Pubmed:29597041 |
| Clinical and Experimental Medicine | Senescence-associated miR-34a and miR-126 in middle-aged Indians with type 2 diabetes Pubmed: 31732824 |
| MOLECULAR AND CELLULAR BIOCHEMISTRY | Tumor suppressor genes are differentially regulated with dietary folate modulations in a rat model of hepatocellular carcinoma Pubmed: 32974833 |

